337 related articles for article (PubMed ID: 35230691)
21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
22. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
23. Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data.
Rivers A; Jagadeeswaran R; Lavelle D
Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R840-R847. PubMed ID: 30067082
[TBL] [Abstract][Full Text] [Related]
24. Investigating the Biological Relevance of
Kotta-Loizou I; Peyret H; Saunders K; Coutts RHA; Lomonossoff GP
J Virol; 2019 May; 93(9):. PubMed ID: 30814279
[TBL] [Abstract][Full Text] [Related]
25. Pericytes in Breast Cancer.
Kim J
Adv Exp Med Biol; 2019; 1147():93-107. PubMed ID: 31147873
[TBL] [Abstract][Full Text] [Related]
26. Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patients.
Mozzillo N; Ascierto P
Clin Exp Metastasis; 2012 Oct; 29(7):801-5. PubMed ID: 22752507
[TBL] [Abstract][Full Text] [Related]
27. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
Colombini D; Occhipinti E
Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
[TBL] [Abstract][Full Text] [Related]
28. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
29. Suicide among agricultural, forestry, and fishery workers.
Shiri R
Scand J Work Environ Health; 2018 Jan; 44(1):106-107. PubMed ID: 29214320
[TBL] [Abstract][Full Text] [Related]
30. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
32. Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to.
Brady R; Enderling H
Bull Math Biol; 2019 Oct; 81(10):3722-3731. PubMed ID: 31338741
[TBL] [Abstract][Full Text] [Related]
33. Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression.
Sorscher S
Breast Cancer Res Treat; 2019 Nov; 178(2):469-471. PubMed ID: 31392519
[TBL] [Abstract][Full Text] [Related]
34. First Report of Root-Knot Nematode (
Gao J; Zhao W; Qin Z; Chen L; Li M; Zhang J; Yang Q
Plant Dis; 2023 Mar; ():. PubMed ID: 36935385
[No Abstract] [Full Text] [Related]
35. Ocular ultraviolet radiation exposure of welders.
Tenkate TD
Scand J Work Environ Health; 2017 May; 43(3):287-288. PubMed ID: 28295119
[TBL] [Abstract][Full Text] [Related]
36. Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo.
Delekta PC; Dobry CJ; Sindac JA; Barraza SJ; Blakely PK; Xiang J; Kirchhoff PD; Keep RF; Irani DN; Larsen SD; Miller DJ
J Virol; 2014 Oct; 88(19):11199-214. PubMed ID: 25031353
[TBL] [Abstract][Full Text] [Related]
37. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
38. Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Evaluation of Saglio G, Kim D-W, Issaragrisil S, et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 2010;362:2251-9, and Kantarjian H, Shah NP, Hochhaus A, et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2010;362:2260-70.
Doggrell SA; Christensen AM
Expert Opin Pharmacother; 2011 Jan; 12(1):157-63. PubMed ID: 21108601
[TBL] [Abstract][Full Text] [Related]
39. Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Hockenhull J; Proudlove C; Dundar Y; Richardson M; Dickson R; Mullard A; Marshall E
Health Technol Assess; 2015 Jun; 19(47):1-134. PubMed ID: 26134145
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
